KalVista has licenced the commercialisation rights for sebetralstat, a hereditary angioedema (HAE) treatment, to Kaken in ...

The UK Government has announced a £600m ($764m) funding pot to create a new Health Data Research Service, reducing red tape ...

US President Donald Trump told reporters last week that pharma tariffs are coming “sometime in the near future”.

Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory ...

Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, and Eli Lilly’s Kisunla (donanemab) in July ...

US policy changes to withdraw from the WHO and cut USAID have had clinical repercussions throughout Africa. We explore the ...

The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag International’s Darzalex ...

RFK Jr supported the MMR vaccine’s efficacy in preventing measles, but also shared unproven treatment strategies.

Following the launch of the first disease-modifying therapies for Alzheimer’s disease, a key theme at the AD/PD 2025 ...

Rhythm's Imcivree has shown benefit in a Phase III trial in patients with acquired hypothalamic obesity, leading to 19.8% ...

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...

ABL Bio has announced a global licensing agreement with GSK, allowing the latter to develop medicines for neurodegenerative ...